AMOR-1
- Generic Name
- AMOR-1
Evaluating the Safety and Efficacy of AMOR-1 As a Treatment for Hypocalcemia Associated with Hypoparathyroidism in Adults
Phase 2
Recruiting
- Conditions
- Hypoparathyroidism
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Amorphical Ltd.
- Target Recruit Count
- 81
- Registration Number
- NCT06547151
- Locations
- 🇮🇱
Soroka Medical Center, Beer Sheva, Israel
🇮🇱Hadassah Ein Kerem Medical Center, Jerusalem, Israel
🇮🇱Barzilai Medical Center, Ashkelon, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath